Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NextCure, Inc. Director's Dealing 2020

Sep 15, 2020

35069_dirs_2020-09-14_e5c6a6cd-850e-4702-a420-da56429d1187.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2020-09-10

Reporting Person: Houston John G (Director)

More from NextCure, Inc.

Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 12
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Director's Dealing 2026
Feb 3
Major Shareholding Notification 2026
Jan 29
View all filings →